Cas no 131906-57-5 (1-(4-hexylphenyl)-2-propen-1-one)
131906-57-5 structure
Product Name:1-(4-hexylphenyl)-2-propen-1-one
CAS No:131906-57-5
MF:C15H20O
MW:216.318704605103
CID:898801
PubChem ID:24724504
Update Time:2025-04-19
1-(4-hexylphenyl)-2-propen-1-one Chemical and Physical Properties
Names and Identifiers
-
- 1-(4-hexylphenyl)-2-propen-1-one
- 1-(4-hexylphenyl)prop-2-en-1-one
- 1-(4-Hexyphenyl)-2-propane-1-one
- cpd L3, L3 Antagonist TR-SIR-2
- L3 Antagonist TR-SIR-2
- cpd L3
- cpd L3, L3 Antagonist TR-SIR-2
- DB08085
- NS00071003
- DTXCID70515919
- MA965OF9ZR
- 131906-57-5
- DTXSID40565143
- NCGC00165805-02
- PD004761
- BDBM18825
- NCGC00165805-01
- Q27097314
- MFCD08702653
- CHEMBL237600
- UNII-MA965OF9ZR
- J-006082
- 2-Propen-1-one, 1-(4-hexylphenyl)-
- SCHEMBL2583757
- Enone, 1
-
- MDL： MFCD08702653
- Inchi： 1S/C15H20O/c1-3-5-6-7-8-13-9-11-14(12-10-13)15(16)4-2/h4,9-12H,2-3,5-8H2,1H3
- InChI Key： IINHTEWASPUCMH-UHFFFAOYSA-N
- SMILES： O=C(C=C)C1C=CC(=CC=1)CCCCCC
Computed Properties
- Exact Mass: 216.1515
- Monoisotopic Mass: 216.151415257g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 16
- Rotatable Bond Count: 7
- Complexity: 212
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.9
- Topological Polar Surface Area: 17.1?2
Experimental Properties
- Density: 0.935
- Boiling Point: 320.627°C at 760 mmHg
- Flash Point: 133.809°C
- Refractive Index: 1.506
- Solubility: DMSO: >5mg/mL
- PSA: 17.07
- LogP: 4.17810
1-(4-hexylphenyl)-2-propen-1-one Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1942242-5mg |
1-(4-Hexylphenyl)prop-2-en-1-one |
131906-57-5 | 98% | 5mg |
￥3967.00 | 2024-08-09 | |
| SHENG KE LU SI SHENG WU JI SHU | sc-251468-5 mg |
1-(4-Hexyphenyl)-2-propane-1-one, |
131906-57-5 | 5mg |
￥2,632.00 | 2023-07-11 | ||
| SHENG KE LU SI SHENG WU JI SHU | sc-251468-5mg |
1-(4-Hexyphenyl)-2-propane-1-one, |
131906-57-5 | 5mg |
￥2632.00 | 2023-09-05 |
1-(4-hexylphenyl)-2-propen-1-one Related Literature
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
-
Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
131906-57-5 (1-(4-hexylphenyl)-2-propen-1-one) Related Products
- 768-03-6(1-Phenyl-2-propen-1-one (Contains ~1% BHT as stabilizer))
- 959-28-4((E)-1,4-Diphenylbut-2-ene-1,4-dione)
- 548-08-3(Roemerine)
- 495-41-0(1-Phenyl-2-buten-1-one)
- 4070-75-1(2-Butene-1,4-dione,1,4-diphenyl-)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
Recommended suppliers
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
Shanghai Jinhuan Chemical CO., LTD.
Gold Member
Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
Handan Zechi Trading Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
